Sustained Release Excipients Market Size, Share, Opportunities, And Trends By Product (Gelatin, Polymers, Minerals, Sugars, Alcohol, Chitosan), By Technology (Targeted Delivery, Micro Encapsulation, Wurster Technique, Transdermal, Implants, Coacervation, Other), By Route of Administration (Oral, Intramuscular, Subcutaneous, Transdermal, Vaginal, Ophthalmic, Intravenous, Others), And By Geography - Forecasts From 2023 To 2028

The sustained release excipients market is estimated to grow at a CAGR of 5.96% during the forecast period.

In contrast to an immediate-release dose, a sustained release excipients dosage provides a medication after ingestion or over a longer length of time, such as an extended-release. The sustained-release drugs are frequently employed in tablets and capsules. Delivery is often achieved by the active compound's excipient dissolving, deteriorating, or integrating. Release profiles can also be changed by encapsulation techniques like enteric coating.

Growth drivers for sustained release excipients market

The sustained release excipients market's expansion has been significantly impacted by the rising number of patent expirations and the rising need for dosage forms for the elderly and pediatric populations. As patient expectations for greater convenience rise, so does the need for controlled-release formulations. The primary ingredients in controlled-release formulations are excipients. The business is expected to be driven by growing public awareness of the additional advantages of controlled-release formulations. Excipients that aid the drug's prolonged release are used to create medications from a variety of active medicinal substances.

The transdermal sustained-release delivery method shows growth potential

Transdermal sustained-release delivery methods are stronger and have a longer shelf life than the other types of excipients used in various medical compositions. Pharmaceutical polymers have improved over the past several years from being used to make simple gelatin capsules to strengthening excipient capsules with good formulation qualities that promote controlled/sustained release and help with medication distribution to target locations. Additionally, a surge in the number of formulations utilizing polyethylene glycol over the past few years has led to significant demand for the substance. Thus, it is predicted that increased polymer use would promote sustained release excipients market.

Increasing use of oral drugs

Oral drug delivery methods are used more in contrast to other delivery methods due to the availability of the highest active surface for drug absorption. Additionally, the simplicity of producing capsules and tablets is another factor influencing the sustained release excipients market share. Excipients that aid the drug's prolonged release are used to create medications from a variety of active medicinal substances. If a producer is creating a sustained-release version of an already-known chemical, getting FDA clearance is not too difficult.

Global rise in antibiotic resistance

The main contributors to antibiotic resistance have been recognized as excessive and improper usage of traditional medication formulations. Sometimes after receiving medication, patients get better quickly and stop taking the prescribed dosage, which leads to resistance. Such resistance causes an increase in the mortality rate, longer hospital stays, and higher medical expenses. Antibiotic resistance has also been brought on by the growth in the prevalence of infectious and chronic illnesses, which has had a detrimental effect on the market for traditional dosage forms. As a result, various methods of treating and controlling these disorders are being used which impacts the sustained release excipients market share.

Sustained Release Excipients market opportunity

The largest subset of the drug delivery business, oral medication delivery, is growing rapidly. As a result, the oral delivery drug market with an expected growth of up to ten percent annually. Pharmaceutical companies are turning to drug delivery to the extent of the revenue-earning of their products and the increase in the elderly population. The market for oral-delivery pharmaceuticals is definitively broken out under Oral Delivery.

The North American sustained release excipients are anticipated to grow significantly.

The North American sustained release excipients industry is anticipated to grow at a constant CAGR and keep the top spot for the whole period of the prediction. Presence of various pharmaceutical businesses and increased R&D efforts are fueling the North American sustained release excipients industry. The sustained release excipients market expansion in North America is further supported by growing regional cooperation between healthcare organizations to raise awareness of chronic illnesses and accessible treatment choices.

Asia Pacific region is predicted to show growth potential

The quickly evolving healthcare system in the Asia Pacific region is fueling the sustained release excipients industry. Additionally, numerous infectious illnesses and extremely potent treatments upsurge the market. Particularly in the Asia Pacific area, China is a rising sustained release excipients market. To take advantage of this, the majority of worldwide excipient suppliers are proposing to set up production facilities in the nation. These are a few of the elements influencing the APAC region's expansion.

Market Strategies by key players

To increase their market position, key firms are putting numerous tactics into practice, such as alliances formed through mergers and acquisitions, regional expansions, and strategic collaborations. DuPont successfully combined its Nutrition & Biosciences Business with International Flavours & Fragrances in February 2021. The range has expanded with the inclusion of Aquacoat products, increasing the number of options available to satisfy market demands. Many such product innovations are being made by the players which is upsurging the sustained release excipients market share.

Market Key Developments

• In June 2023, Croda, Inc. announced that the construction had begun on a new manufacturing facility to be situated in Pennsylvania, United States. This facility is projected to increase Croda's manufacturing capacity and better satisfy the evolving needs in the sustained release excipients market.
• In June 2023, International Flavours & Fragrances, Inc. announced the launch of its unique oral excipients in China, including goods like METHOCEL.
• In November 2022, Pearlitol CR-H, which improves API's sustained release in compression formulations, was introduced by Roquette Frères.

Segmentation:

• By Product
  • Gelatin
  • Polymers
  • Minerals
  • Sugars
  • Alcohol
  • Chitosan
• By Technology
  • Targeted Delivery
  • Micro Encapsulation
  • Wurster Technique
  • Transdermal
  • Implants
  • Coacervation
  • Other
• By Route of Administration
  • Oral
  • Intramuscular
  • Subcutaneous
  • Transdermal
  • Vaginal
  • Ophthalmic
  • Intravenous
  • Others
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • United Kingdom
    • Germany
    • France
    • Spain
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Israel
    • Others
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Indonesia
    • Thailand
    • Others

1.  INTRODUCTION

1.1. Market Overview

1.2. Market Definition

1.3. Scope of the Study

1.4. Market Segmentation

1.5. Currency

1.6. Assumptions

1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY  

2.1. Research Data

2.2. Assumptions

3. EXECUTIVE SUMMARY

3.1. Research Highlights

4. MARKET DYNAMICS

4.1. Market Drivers

4.2. Market Restraints

4.3. Porter’s Five Force Analysis

4.3.1. Bargaining Power of Suppliers

4.3.2. Bargaining Power of Buyers

4.3.3. Threat of New Entrants

4.3.4. Threat of Substitutes

4.3.5. Competitive Rivalry in the Industry

4.4. Industry Value Chain Analysis

5. SUSTAINED RELEASE EXCIPIENTS MARKET, BY PRODUCT

5.1. Introduction

5.2. Gelatin

5.3. Polymers

5.4. Minerals

5.5. Sugars

5.6. Alcohol

5.7. Chitosan

6. SUSTAINED RELEASE EXCIPIENTS MARKET, BY TECHNOLOGY

6.1. Introduction

6.2. Targeted Delivery

6.3. Micro Encapsulation

6.4. Wurster Technique

6.5. Transdermal

6.6. Implants

6.7. Coacervation

6.8. Other

7. SUSTAINED RELEASE EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION

7.1. Introduction

7.2. Oral

7.3. Intramuscular

7.4. Subcutaneous

7.5. Transdermal

7.6. Vaginal

7.7. Ophthalmic

7.8. Intravenous

7.9. Others

8. SUSTAINED RELEASE EXCIPIENTS MARKET, BY GEOGRAPHY

8.1. Introduction

8.2. North America

8.2.1. United States

8.2.2. Canada

8.2.3. Mexico

8.3. South America

8.3.1. Brazil

8.3.2. Argentina

8.3.3. Others

8.4. Europe

8.4.1. United Kingdom

8.4.2. Germany

8.4.3. France

8.4.4. Spain

8.4.5. Others

8.5. The Middle East and Africa

8.5.1. Saudi Arabia

8.5.2. UAE

8.5.3. Israel

8.5.4. Others

8.6. Asia Pacific

8.6.1. Japan

8.6.2. China

8.6.3. India

8.6.4. South Korea

8.6.5. Indonesia

8.6.6. Thailand

8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

9.1. Major Players and Strategy Analysis

9.2. Emerging Players and Market Lucrativeness

9.3. Mergers, Acquisitions, Agreements, and Collaborations

9.4. Vendor Competitiveness Matrix

10. COMPANY PROFILES

10.1. BASF

10.2. International Flavors & Fragrances, Inc.

10.3. Ashland Global

10.4. Evonik Industries

10.5. Croda International Plc

10.6. Gattefossé

10.7. Merck KGaA

10.8. MEGGLE Pharma

10.9. Sigma-Aldrich

BASF

International Flavors & Fragrances, Inc.

Ashland Global

Evonik Industries

Croda International Plc

Gattefossé

Merck KGaA

MEGGLE Pharma

Sigma-Aldrich